Clinical Trial Update: Gut Microbiome and p-Inulin in CKD - TarGut CKD Study [NA]

View source ↗

Summary

This document provides an update on the TarGut CKD study examining the effects of gut microbiome modulation using p-inulin in chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• p-inulin (inulin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Kidney Diseases | NA | Status: UNKNOWN